This CME Newsletter will review and discuss the key studies on antiretroviral therapy presented during CROI 2011. Contributors to this newsletter are from a distinguished faculty panel in the field of HIV, including the course director, Calvin Cohen from the Harvard University School of Medicine. This activity has been designed to meet the educational needs of physicians involved in the care of patients with HIV infection.
This program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine.
This activity has been designed to meet the educational needs of physicians involved in the care of patients with HIV infection.
After completing this activity, participants should be able to:
Explain the key new studies on ARV therapy presented during CROI 2011
Employ the advances in clinical management of HIV-positive patients presented and discussed during CROI 2011
Apply data presented during CROI 2011 regarding the treatment of ARV-naïve and experienced patients
Release Date: April 12, 2011
Expiration Date: April 12, 2012
Estimated time to complete the CROI CME Newsletter: 1 hour
Media: Internet
Calvin J. Cohen, MD, MS
Research Director,
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts
José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain
John Bartlett, MD
Professor, Johns Hopkins University
School of Medicine
Baltimore, Maryland
David Cooper, MD
Professor, University of New South Wales
Director of The National Centre in Epidemiology & Clinical Research
Sydney, Australia
Edwin DeJesus, MD
Medical Director
Orlando Immunoloty Center
Orllando, FL
Joseph Eron, MD
Professor,
University of North Carolina School of Medicine
Chapel Hill, North Carolina
Ian Frank, MD
Professor of Medicine,
Director, Antiretroviral Clinical Research
University of Pennsylvania
Philadelphia, Pennsylvania
Jurgen Rockstroh, MD
Professor, University of Bonn
Bonn, Germany
Paul Sax, MD
Clinical Director,
Brigham and Women's Division of
Infectious Diseases and HIV Program
Associate Professor of Medicine,
Harvard Medical School
Boston, Massachusetts
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, Inc.. PIM is accredited by the ACCME to provide continuing medical education for physicians.
PIM designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Dr. John Bartlett:
Dr. Jose Arribas:
Dr. David Cooper:
Dr. Calvin Cohen:
Dr. Edwin DeJesus:
Dr. Joseph Eron:
Dr. Ian Frank:
Dr. Juergen Rockstroh:
Dr. Paul Sax:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchison, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine (PIM), ViralEd, Inc. and Merck & Co. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ViralEd, Inc. and Merck & Co. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There are no fees for participating and receiving credit for this activity. During the period, April 12, 2011 through April 12, 2012 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
You may complete the post-test online at: www.cmeuniversity.com
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Supported by an educational grant from Merck & Co., Inc.
*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings
